Nutrition, microbiome and multiple sclerosis. Current knowledge from basic research and clinical practice

被引:0
|
作者
Haghikia, A. [1 ]
Linker, R. A. [2 ]
机构
[1] Ruhr Univ Bochum, St Josef Hosp, Neurol Klin, Gudrunstr 56, D-44971 Bochum, Germany
[2] Univ Klinikum Erlangen, Neurol Klin, Schwabachanlage 6, D-91054 Erlangen, Germany
来源
NERVENARZT | 2018年 / 89卷 / 04期
关键词
Pathogenesis; Salt; Fatty acid; Smoking; Alcohol; ENVIRONMENTAL RISK-FACTORS; DIETARY-SODIUM INTAKE; BODY-MASS INDEX; FATTY-ACIDS; AUTOIMMUNE-DISEASE; GUT MICROBIOTA; CELLS; MS; DEMYELINATION; METABOLITES;
D O I
10.1007/s00115-018-0497-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Epidemiological data indicate a disproportional increase in the incidence of multiple sclerosis (MS) over the last decades, particularly in industrialized countries. Although this increase is also associated with altered diagnostic criteria and improved sensitivity of imaging procedures, current data suggest that particularly alterations in our way of life play an important role. In recent years the importance of the gut and intestinal microbiome for some neurological diseases and in particular for MS was recognized. Because nutritional habits have a substantial influence on the composition of the microbiome and our nutrition has changed considerably in the last decades, nutritional components can play an important role in the pathogenesis of MS. In this further education article we summarize the currently available evidence on the role of the gut and on the effects of dietary components on the microbiome in the pathogenesis of MS.
引用
收藏
页码:463 / 471
页数:9
相关论文
共 50 条
  • [1] The clinical neuropsychiatry of multiple sclerosis.
    Munk-Jorgensen, P
    ACTA PSYCHIATRICA SCANDINAVICA, 2000, 102 (01) : 78 - 78
  • [2] Mitoxantrone therapy in multiple sclerosis.: Safety and efficacy in daily clinical practice
    Boscà, I
    Casanova, B
    Coret, F
    Piera, A
    Boscá, M
    JOURNAL OF NEUROLOGY, 2005, 252 : 64 - 64
  • [3] The Results of Twin Research in multiple Sclerosis.
    Thums, Karl
    NERVENARZT, 1939, 12 (09): : 463 - 469
  • [4] Microbiome and nutrition in autism spectrum disorder: current knowledge and research needs
    Berding, Kirsten
    Donovan, Sharon M.
    NUTRITION REVIEWS, 2016, 74 (12) : 723 - 736
  • [5] Ernährung, Mikrobiom und Multiple SkleroseAktuelle Erkenntnisse aus der Grundlagenforschung und der KlinikNutrition, microbiome and multiple sclerosisCurrent knowledge from basic research and clinical practice
    A. Haghikia
    R. A. Linker
    Der Nervenarzt, 2018, 89 (4) : 463 - 471
  • [6] ECTRIMS-EAN clinical practice guideline on pharmacological management of multiple sclerosis.
    Otero-Romero, S.
    Amato, M. P.
    Chandraratna, D.
    Clanet, M.
    Comi, G.
    Derfuss, T.
    Fazekas, F.
    Hemmer, B.
    Hartung, H. -P.
    Havrdova, E.
    Kappos, L.
    Liblau, R.
    Lubetzki, C.
    Miller, D. H.
    Olsson, T.
    Selmaj, C.
    Siva, A.
    Sorensen, P. S.
    Thalheim, C.
    Wiendl, H.
    Zipp, F.
    Thompson, A. J.
    Gold, R.
    Montalban, X.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 834 - 834
  • [7] Axonal involvement in multiple sclerosis. Current concepts
    Casanova-Estruch, B
    Coret-Ferrer, F
    Landete, L
    Burgal, M
    REVISTA DE NEUROLOGIA, 2000, 30 (10) : 972 - 976
  • [8] Clinical magnetic resonance spectroscopy of multiple sclerosis.
    Riedy, G
    Gibbons, C
    Vollmer, T
    Pringer, E
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (01) : A115 - A115
  • [9] Headache in Multiple Sclerosis. Clinical and Therapeutical Correlations
    Monaldini, Chiara
    Capone, Jay Guido
    Caniatti, Maria Luisa
    Casetta, Ilaria
    Guttmann, Susanna
    Granieri, Enrico
    Tola, Maria Rosaria
    NEUROLOGY, 2010, 74 (09) : A365 - A365
  • [10] Plasmapheresis as rescue therapy of relapses in multiple sclerosis. A retrospective clinical practice survey.
    Curti, E.
    Sassi, M.
    Tsantes, E.
    Siena, E.
    Pesci, I.
    Soli, M.
    Risi, B.
    Granella, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 325 - 325